Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Annapolis Ledger.
Press releases published on May 8, 2025
APV Honored with 2025 ACT-IAC Innovation Champion Award for Transformative AR/AI Emergency Response Solution
EIN Presswire
·
May 8, 2025
Award-winning AR/AI platform, developed with the Air Force, boosts emergency response training and modernizes government operations. COLUMBIA, MD, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- APV was honored to receive a 2025 Innovation Champion …
Vision 2030: GBAC Board Study—Saudi MSCI Top‑10 Lead in ESG, AI, Independence
EIN Presswire
·
May 8, 2025
GBAC benchmark reveals Saudi boards outpace GCC peers and align with OECD, ESG, and AI standards—positioning the Kingdom for global FDI leadership. WASHINGTON D.C, MD, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- Vision 2030 Boards Surpass Global …
Over 200 Recruits Compete, Offers Fly at NCEC DMV Camp at Morgan State
EIN Presswire
·
May 8, 2025
Over 200 Recruits Compete, Offers Fly at NCEC DMV Camp at Morgan State BALTIMORE, MD, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- NCEC DMV Camp at Morgan State Spotlights Next Wave of Talent The first-ever NCEC (National College Evaluation Camp …
Cloudforce and Microsoft Support the Launch of TerpAI at UMD’s Bitcamp 2025, Advancing AI Innovation in Higher Ed
EIN Presswire
·
May 8, 2025
NATIONAL HARBOR, MD, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- Innovation took center stage at the University of Maryland’s (UMD) 11th annual Bitcamp hackathon, the largest collegiate hackathon on the East Coast, where more than 1,000 students …
Beacon Public Health Launches the Public Health Impact Academy to Empower Public Health Equity Leaders
EIN Presswire
·
May 8, 2025
Launching the Public Health Impact Academy, an initiative designed to equip public health professionals with the tools needed to improve health outcomes. WASHINGTON, MD, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- Beacon Public Health Launches the …
RadSite Announces First Accreditation for Cone Beam Breast CT Imaging in the US
EIN Presswire
·
May 8, 2025
The Painless Mammogram medical practice and the Koning Vera breast CT imaging system are the first to be accredited ANNAPOLIS, MD, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- RadSite™, a leading accreditation organization promoting quality-based …
Emerald Intel Tackles CRM Data Decay With Real-Time Update Notifications
EIN Presswire
·
May 8, 2025
HubSpot and Salesforce CRM users now benefit from real-time alerts when CRM data updates are available, improving data quality and accuracy BETHESDA, MD, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- Emerald Intel, a leading SaaS provider dedicated …
Senseonics Holdings, Inc. Reports First Quarter Financial Results
GlobeNewswire
·
May 8, 2025
Q1 Revenue of $6.3 million, growth year over year of 24% Partnership with Sequel integrates twiist™ automated insulin delivery (AID) system with Eversense® 365 one-year continuous glucose monitor (CGM); twiist with Eversense 365 launch expected in Q3 …
Elutia Announces Strong First Quarter 2025 Financial Results Driven by 84% Sequential Growth in EluPro™ Sales
GlobeNewswire
·
May 8, 2025
- New Boston Scientific distribution partnership now underway - - Conference call today at 5:00 p.m. ET / 2:00 p.m. PT - SILVER SPRING, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting …
Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial
GlobeNewswire
·
May 8, 2025
GAITHERSBURG, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …
New Book When in Doubt, Call 91:1 Explores Faith, Healing, and Redemption Through Life’s Deepest Struggles
EIN Presswire
·
May 8, 2025
WALDORF, MD, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- In her deeply personal and inspiring new memoir, When in Doubt, Call 91:1, Rhonece Ford takes readers on an emotional journey of faith, loss, and healing. Through raw storytelling and powerful …
Celebrate National Honor Our LGBT Elders Day on May 16
GlobeNewswire
·
May 8, 2025
Baltimore, May 08, 2025 (GLOBE NEWSWIRE) -- Celebrate an LGBT elder who made a difference in your life, and spread the word about the importance of LGBT older adults in your community on Friday, May 16—National Honor Our LGBT Elders Day. Join us as we …
Xometry to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 8, 2025
NORTH BETHESDA, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Xometry, Inc. (NASDAQ:XMTR), the global AI-powered marketplace digitizing manufacturing and driving greater supply chain resiliency, today announced that management will attend the following investor …
MarketWise Reports Net Revenue of $83.5 Million for First Quarter 2025 and Net Income of $16.8 Million; First Quarter Billings Increase 27% from Prior Quarter; Cash From Operating Activities Improves by $20.2 Million; Provides FY 2025 Financial…
GlobeNewswire
·
May 8, 2025
BALTIMORE, May 08, 2025 (GLOBE NEWSWIRE) -- MarketWise, Inc. (NASDAQ: MKTW) (“MarketWise” or the “Company”), a leading multi-brand digital subscription services platform that provides premium financial research, software, education, and tools for self- …
Altimmune Presents New Analyses Predicting High Rates of MASH Resolution on Biopsy following Pemvidutide Treatment at the EASL International Liver Congress™
GlobeNewswire
·
May 8, 2025
GAITHERSBURG, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing next-generation peptide-based therapeutics for liver and cardiometabolic diseases, today announced the …
Cartesian Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 8, 2025
Initiation of Phase 3 AURORA trial of Descartes-08 in myasthenia gravis expected in 2Q25; deep and sustained benefits observed through Month 12 after a single course of therapy in Phase 2b trial Preliminary data from Phase 2 trial of Descartes-08 in …
Autolus Therapeutics Reports First Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
May 8, 2025
Company reports Q1 2025 AUCATZYL® net product revenue of $9.0 million U.K. Medicines and Healthcare products Regulatory Agency (MHRA) granted conditional marketing authorization for AUCATZYL® for the treatment of adult patients with relapsed or refractory …
Liquidity Services Announces Second Quarter Fiscal Year 2025 Financial Results
GlobeNewswire
·
May 8, 2025
BETHESDA, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Liquidity Services (NASDAQ:LQDT; www.liquidityservices.com), a leading global commerce company powering the circular economy, today announced its financial results for its fiscal quarter ended March 31, 2025, …